Doris Lachmann

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Deutsches Konsortium für Translationale Krebsforschung(Current)

Doris Lachmann is an author at Deutsches Konsortium für Translationale Krebsforschung specializing in antimitotic activity, glioblastoma, and antimitotic drugs.

ORCID

Publications per year

2023–2023

Publications

Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent Glioblastomas

Dietmar Krex, Paula Bartmann, Doris Lachmann et al. · International Journal of Molecular Sciences · 2023 · 11 citations · Full text

Medicine, Oncology, Pharmacology +15

1–1 of 1